To assess the safety of nonconforming lisocabtagene maraleucel in patients
Thank you for your interest, but this study is recruiting by invitation only.
North Carolina (Statewide)
Natalie Grover
Medicine- Oncology
Clinical or Medical
Interventional
Cancer (Lymphoma)
20-1240
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
